glycopeptide,neutral_mass,mass_accuracy,ms1_score,ms2_score,q_value,total_signal,start_time,end_time,apex_time,charge_states,msms_count,peptide_start,peptide_end,protein_name,mass_shifts
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:3; Hex:5; HexNAc:4},4443.109769376249,-1.0970521576407334e-06,-21.5209130169,33.5535666526,0,9322794,84.4190390772,84.5130714085,84.513071408494,3;4,1,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4442.112868205781,-6.387555864174422e-06,-0.421128428574,30.1486338626,0,53354012.5,84.4036032266,84.4974879251,84.434836561108,3;4,2,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:1; Hex:5; HexNAc:4},3999.8217020045345,-9.702877039670373e-06,-5.70413818125,19.2408084986,0.00751879699248,12322515.5,74.3760734783,74.4704561776,74.438943158213,3,2,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,Unmodified
GTAGNALMDGASQLM(Oxidation)GEN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:4},3822.57828688,-8.97352852096e-06,0,26.0508397456,0,0,,,,3,1,376,395,sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2,
N(N-Glycosylation)NTRGPGLKR{Fuc:1; Hex:5; HexNAc:5},3083.358297037557,-5.957849879121379e-06,16.8239566538,85.9568636932,0,548640912.0,33.5837282445,33.847665245,33.715104860687,3;4,4,787,797,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0476781666107,-3.4478170547381956e-06,16.2329674259,110.793133496,0,1489404318.0,27.2260027753,27.6812231924,27.364523727322,2;3,4,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:5; HexNAc:2},2325.0349135696397,-1.048538764627077e-05,16.158312859,131.598691435,0,462538893.0,52.2816822595,52.7353822257,52.508643991375,2,2,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:4; HexNAc:2},2162.977375268968,-9.09117701040911e-06,11.8199233221,108.884054359,0,118405901.0,52.7207176433,53.0231956111,52.826079291725,2,1,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:3; HexNAc:4},4407.146254560854,-4.854512380304922e-06,-2.53576490618,42.2580723967,0,210888910,96.0203474746,96.0669345246,96.020347474639,4,3,126,153,sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=3,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4819.289970351641,-9.009524877938548e-06,-2.38199837493,39.1784859785,0,123942478,96.2032569434,96.2332919107,96.203256943448,4,2,126,153,sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=3,Unmodified
VVLHPN(N-Glycosylation)YSQVDIGLIK{Hex:5; HexNAc:4; Neu5Ac:2},3998.8145373205434,-9.53468998818032e-06,13.7536120445,23.7563961454,0,146320026.5,74.4548781103,74.7717644439,74.565540594482,3,1,235,251,sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1,Unmodified
VVLHPN(N-Glycosylation)YSQVDIGLIK{Hex:5; HexNAc:4; Neu5Ac:2},3998.76309526,3.32968060437e-06,0,11.9346434233,0.0368098159509,0,,,,3,1,235,251,sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1,
N(N-Glycosylation)ISDGFDGIPDNVDAALALPAHSYSGR{Hex:5; HexNAc:4; Neu5Ac:2},4976.11451195137,-5.423055752856338e-06,-20.2629911969,23.3256971589,0,7242916.5,90.1512645271,90.1512645271,90.151264527067,4,1,241,268,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,Unmodified
N(N-Glycosylation)GSLFAFR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3116.25778513,3.71280676724e-07,0,13.9550260725,0.0120481927711,0,,,,3,1,168,176,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,
EEQFN(N-Glycosylation)STFR{Fuc:1; Hex:3; HexNAc:4},2601.0711237073474,-8.593785207788947e-06,16.902114638,112.214371425,0,1337544816.375,39.9744299279,40.5122074749,40.214983092372,2;3,4,171,180,sp|P01859|IGHG2_HUMAN Immunoglobulin heavy constant gamma 2 OS=Homo sapiens OX=9606 GN=IGHG2 PE=1 SV=3,Unmodified
EEQFN(N-Glycosylation)STFR{Fuc:1; Hex:4; HexNAc:4},2763.1263911888063,-8.974294330311713e-06,14.1480352394,65.1188694214,0,677844910.625,39.5902903941,40.2446652597,40.065339842065,2;3,4,171,180,sp|P01859|IGHG2_HUMAN Immunoglobulin heavy constant gamma 2 OS=Homo sapiens OX=9606 GN=IGHG2 PE=1 SV=3,Unmodified
GHVN(N-Glycosylation)ITR{Hex:5; HexNAc:4; Neu5Ac:2},3000.215537737214,-2.6539652381674116e-06,14.5105742689,67.3460684749,0,656371223.0,27.6812231924,28.1876235432,27.817253242556,3,2,117,124,sp|P00734|THRB_HUMAN Prothrombin OS=Homo sapiens OX=9606 GN=F2 PE=1 SV=2,Unmodified
GHVN(N-Glycosylation)ITR{Hex:5; HexNAc:6; Neu5Ac:1},3115.2573016511765,4.366300926915783e-06,12.2630333575,15.2509902672,0.0120481927711,22961975.75,71.4634854422,71.8178302751,71.617602426434,3,1,117,124,sp|P00734|THRB_HUMAN Prothrombin OS=Homo sapiens OX=9606 GN=F2 PE=1 SV=2,Unmodified
LISAQHN(N-Glycosylation)QSKAIEERYAALLK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4442.037317464387,-9.959427086949209e-08,-5.14819619725,18.2639208859,0.00751879699248,14230451.5,53.7525111264,53.8885860946,53.752511126423,4,1,1994,2015,"sp|P02549|SPTA1_HUMAN Spectrin alpha chain, erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTA1 PE=1 SV=5",Unmodified
VQKQQVFEKELAVN(N-Glycosylation)K{Hex:5; HexNAc:4; Neu5Ac:1},3700.7135217564846,-1.1447740227801952e-05,11.8164776751,14.8460172885,0.0204081632653,35484554.75,60.9724209414,61.1890292273,61.142677627627,3,1,619,634,"sp|P02549|SPTA1_HUMAN Spectrin alpha chain, erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTA1 PE=1 SV=5",Unmodified
TLFSVIN(N-Glycosylation)NSHNKK{Fuc:1; Hex:4; HexNAc:4},3107.3696367715434,7.057972742332093e-06,10.9650508174,13.6724212094,0.0204081632653,62930584.25,42.2245968249,42.3742197778,42.284773177528,3,2,169,182,sp|Q29RF7|PDS5A_HUMAN Sister chromatid cohesion protein PDS5 homolog A OS=Homo sapiens OX=9606 GN=PDS5A PE=1 SV=1,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:3; HexNAc:4},4407.146254560854,-4.854512380304922e-06,-2.53576490618,42.2580723967,0,210888910,96.0203474746,96.0669345246,96.020347474639,4,3,113,140,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4819.289970351641,-9.009524877938548e-06,-2.38199837493,39.1784859785,0,123942478,96.2032569434,96.2332919107,96.203256943448,4,2,113,140,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
ASSSFQAN(N-Glycosylation)GTK{Hex:3; HexNAc:2},1988.8395319606825,-3.7283741214100607e-06,14.8408168283,109.009267876,0,146732973.75,26.108996978,26.303133995,26.234440694873,2,2,125,136,sp|O96009|NAPSA_HUMAN Napsin-A OS=Homo sapiens OX=9606 GN=NAPSA PE=1 SV=1,Unmodified
IQC(Carbamidomethyl)DIPFFGIQEEFN(N-Glycosylation)ATLK{Hex:4; HexNAc:3; Neu5Ac:1},3817.6508014767087,7.679765262423903e-07,14.4586513883,14.0959006386,0.0204081632653,576427914.5,45.9031794773,46.3051593608,46.155984428151,3;4,4,1029,1048,sp|P11215|ITAM_HUMAN Integrin alpha-M OS=Homo sapiens OX=9606 GN=ITGAM PE=1 SV=2,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:3; Hex:5; HexNAc:4},4443.02460507042,-9.02536832339229e-06,-21.0114443162,43.4845819358,0,3955925,79.7767674949,79.7767674949,79.776767494901,4,1,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
TKTEISEMNRN(N-Glycosylation)ISR{Hex:5; HexNAc:4; Neu5Ac:2},3882.6518463996117,-8.39343873491359e-06,14.0507709034,25.2283791526,0,916305885.25,82.812327928,84.2156989918,83.553684110069,3,5,302,316,"sp|P05787|K2C8_HUMAN Keratin, type II cytoskeletal 8 OS=Homo sapiens OX=9606 GN=KRT8 PE=1 SV=7",Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0476781666107,-3.4478170547381956e-06,16.2329674259,110.793133496,0,1489404318.0,27.2260027753,27.6812231924,27.364523727322,2;3,4,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:6; HexNAc:2},3125.453791861473,-7.402140672389495e-06,16.2585078021,124.539026183,0,921781087.75,73.9401749279,74.4227561261,74.095850645129,2;3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:5; HexNAc:2},2963.410039046064,-1.0867767639147853e-05,17.0878464944,114.420145999,0,759388571.5,74.2675373779,74.7870935943,74.54967135849,2;3,4,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:7; HexNAc:2},3287.5045079963998,-6.396269574169816e-06,14.0662249542,106.654329114,0,336716651.5,73.8002444611,74.0644545104,73.923858891551,2;3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:7; HexNAc:2},3271.5136260943946,-7.660326661680756e-06,13.6542729977,84.4168845033,0,132917278.5,81.9298390772,82.1668085601,82.071794258181,3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:4; HexNAc:2},2801.3499825229965,-8.914468849847362e-06,13.1970219309,19.0420330378,0.00751879699248,142627850.0,74.8024239606,75.1291184253,74.911535241826,3,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
RVN(N-Glycosylation)TTQKR{Fuc:3; Hex:6; HexNAc:5},3427.455235,1.55218564354e-06,0,94.0732158137,0,0,,,,3,2,113,121,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,
RVN(N-Glycosylation)TTQKR{Fuc:1; Hex:6; HexNAc:5},3135.3372002088972,2.4039646269144284e-06,-4.05037608309,72.8626562295,0,16425442.5,76.3842423584,76.4780840264,76.431165276591,3,2,113,121,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,Unmodified
WHRRVN(N-Glycosylation)TTQK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3384.448287181732,-6.217723433425811e-07,10.8421007402,67.3888753303,0,207844864.5,29.9361169285,30.3812867946,30.03687825861,3,2,110,120,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,Unmodified
WHRRVN(N-Glycosylation)TTQK{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3222.3966709862007,-1.0276758724763617e-06,14.0206460396,62.6160902074,0,62547524.5,30.3675347116,30.5244934267,30.424764774863,3,1,110,120,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,Unmodified
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:3; Hex:5; HexNAc:4},3637.58986927,-1.71044160377e-06,0,69.5387146573,0,0,,,,3,2,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:2; Hex:6; HexNAc:4},3653.602158958189,-6.4585450092307345e-06,-4.16956598304,68.2058624192,0,26778589.0,84.8893879082,84.9528197116,84.905072226747,3,2,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
M(Oxidation)IEN(N-Glycosylation)GSLSFLPTLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3652.5824645472726,-6.653718096395205e-06,10.5398647582,66.826415157,0,32791426.25,80.6921402083,81.1143888619,80.988032558187,3,3,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
M(Oxidation)IEN(N-Glycosylation)GSLSFLPTLR{Fuc:2; Hex:6; HexNAc:4},3669.608651315035,-9.585303005749136e-06,9.60737835933,58.8079580164,0,47650846.0,80.9261157777,81.1610721773,80.972335543855,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
LLQVVYLHSNN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3991.79069241701,-8.856263735955483e-06,12.8274651833,20.8615800457,0,204120096.5,64.8005607949,65.2954445944,65.063225411002,3,2,300,314,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
GVFITN(N-Glycosylation)ETGQPLIGK{Hex:6; HexNAc:2},2951.3538712434174,-9.157917937548872e-06,14.6279394895,127.827504572,0,232549305.5,62.8422392752,63.1354408767,62.982565878455,2;3,2,464,479,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
QVVEN(N-Glycosylation)M(Oxidation)TR{Hex:3; HexNAc:2},1883.7981418751313,-2.7851346832828827e-06,16.7763669199,124.563395646,0,251530066.25,24.9852045443,25.2339521593,25.131288308525,2,2,385,393,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
QVVEN(N-Glycosylation)MTR{Hex:3; HexNAc:2},1867.8083604179085,-5.557408639275641e-06,17.505095949,115.85874612,0,794938068.0,30.1245773103,30.5532408264,30.281702811146,2,2,385,393,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
QVVEN(N-Glycosylation)MTR{Hex:4; HexNAc:2},2029.8587916003087,-3.935218672381311e-06,12.8836495103,87.3947586955,0,97573094.5,29.8939498252,30.1388768778,29.950415911897,2,2,385,393,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
DLQNVN(N-Glycosylation)ITLR{Fuc:1; Hex:6; HexNAc:4},3115.3472303193075,-1.1412852516099333e-06,18.4518143782,57.6414177101,0,460043298.0,25.8093813445,25.9952890422,25.881573008124,3;4,4,83,93,sp|P35232|PHB1_HUMAN Prohibitin 1 OS=Homo sapiens OX=9606 GN=PHB1 PE=1 SV=1,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:3; HexNAc:4},4407.146254560854,-4.854512380304922e-06,-2.53576490618,42.2580723967,0,210888910,96.0203474746,96.0669345246,96.020347474639,4,3,228,255,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4819.289970351641,-9.009524877938548e-06,-2.38199837493,39.1784859785,0,123942478,96.2032569434,96.2332919107,96.203256943448,4,2,228,255,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9080424607887,-3.520301855020913e-06,18.7922581744,89.1650202092,0,1343794054.75,28.7627499765,29.0844119257,28.876711359247,2;3,1,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9080424607887,-3.520301855020913e-06,18.7922581744,89.1650202092,0,1343794054.75,28.7627499765,29.0844119257,28.876711359247,2;3,1,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8019128343635,-3.887415466099939e-06,14.9545207719,88.9108488866,0,133934769.5,29.3333037442,29.5153515603,29.390136991564,2,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8019128343635,-3.887415466099939e-06,14.9545207719,88.9108488866,0,133934769.5,29.3333037442,29.5153515603,29.390136991564,2,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:5; HexNAc:4},3124.36373555,-1.85882492604e-06,0,43.8040125617,0,0,,,,2,1,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:5; HexNAc:4},3124.36373555,-1.85882492604e-06,0,43.8040125617,0,0,,,,2,1,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
N(N-Glycosylation)DTASYK{Hex:6; HexNAc:2},2175.824799600298,2.95671891098598e-06,17.0513242663,39.5676670421,0,511469345.5,28.313483511,28.7198338415,28.466010108217,2,1,207,214,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
N(N-Glycosylation)DTASYK{Hex:5; HexNAc:2},2013.772092392895,3.1369444728964903e-06,16.3569124568,10.2621595057,0.0449438202247,386227566.0,28.622153094,28.9601550923,28.777783376598,2,2,207,214,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
DN(N-Glycosylation)ATDSVPLR{Fuc:2; Hex:4; HexNAc:5; Neu5Ac:1},3333.329682349636,6.077892274054752e-06,10.3636180245,12.1088933825,0.0368098159509,145558025.5,45.2993396427,45.6175812747,45.427300876999,3,1,2125,2135,sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2,Unmodified
WDTANNPLYKEATSTFTN(N-Glycosylation)ITYR{Hex:3; HexNAc:3},3700.6617685412775,-5.485376723812931e-06,-21.4861211339,16.295571267,0.00751879699248,2863934.75,77.4227254099,77.4227254099,77.422725409889,3,1,764,786,sp|P05106|ITB3_HUMAN Integrin beta-3 OS=Homo sapiens OX=9606 GN=ITGB3 PE=1 SV=2,Unmodified
GASN(N-Glycosylation)LTWR{Hex:6; HexNAc:2},2281.944684962933,-5.580748563759828e-06,13.2028295741,78.9381295141,0,216173254.5,38.3487860586,38.6603218423,38.526477661355,2,1,401,409,sp|P15586|GNS_HUMAN N-acetylglucosamine-6-sulfatase OS=Homo sapiens OX=9606 GN=GNS PE=1 SV=3,Unmodified
NAIKEGDN(N-Glycosylation)ITLK{Fuc:1; Hex:6; HexNAc:4},3245.4160156174075,-2.8799446735506768e-06,10.1237302109,59.0709526678,0,164219265.0,33.2548041926,33.7003240413,33.612293095016,3;4,1,257,269,sp|Q13740|CD166_HUMAN CD166 antigen OS=Homo sapiens OX=9606 GN=ALCAM PE=1 SV=2,Unmodified
KN(N-Glycosylation)LTLM(Oxidation)ATTSQLPK{Hex:5; HexNAc:5},3386.532207257508,-4.930891211517095e-06,6.44576366355,17.4521552907,0.00751879699248,18321633.25,78.9409891115,79.0656079597,78.956766325855,3,2,265,279,sp|P11117|PPAL_HUMAN Lysosomal acid phosphatase OS=Homo sapiens OX=9606 GN=ACP2 PE=1 SV=3,Unmodified
KN(N-Glycosylation)LTLM(Oxidation)ATTSQLPK{Fuc:3; Hex:6; HexNAc:5},3986.75152225,-2.3738120391e-06,0,10.2990855999,0.046511627907,0,,,,3,1,265,279,sp|P11117|PPAL_HUMAN Lysosomal acid phosphatase OS=Homo sapiens OX=9606 GN=ACP2 PE=1 SV=3,
YHYN(N-Glycosylation)GTLLDGTLFDSSYSR{Hex:8; HexNAc:2},3911.60675017,-0.000258987101727,0,39.3666919715,0,0,,,,3,1,282,301,sp|O95302|FKBP9_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP9 OS=Homo sapiens OX=9606 GN=FKBP9 PE=1 SV=2,
TVDKKN(N-Glycosylation)ISEK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3220.3843606302166,-2.895962649923874e-06,11.5325253405,49.0772069811,0,115743553.0,41.1169380095,41.3680990921,41.247494827334,3,2,1293,1303,sp|Q14966|ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638 PE=1 SV=2,Unmodified
ALVN(N-Glycosylation)FTR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3025.25749228,-1.44245577173e-06,0,60.4482163277,0,0,,,,3,1,85,92,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,
NQELEDNVHISPN(N-Glycosylation)GSIITIVGTRPSNHGTYR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},5477.47488482,-6.8297348593e-06,0,17.2772871123,0.00751879699248,0,,,,5,1,3059,3090,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,
GAPGLAGKN(N-Glycosylation)GTDGQKGK{Fuc:1; Hex:7; HexNAc:3},3444.506860562422,-8.608603051746827e-06,9.66911473521,19.9075873347,0,55611425.0,81.4266858246,81.6137795435,81.520312808577,3,5,318,335,sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,Unmodified
N(N-Glycosylation)KTRVVSYR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3181.3662443754297,-2.425002878423965e-07,12.4885546493,59.0476043957,0,81601060,29.8653836276,29.9788319773,29.921465908114,3,2,452,461,sp|Q14764|MVP_HUMAN Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4,Unmodified
N(N-Glycosylation)KTRVVSYR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3472.4646444133687,-1.0813684466387802e-06,14.1304929916,44.6646418944,0,286890007.0,31.691864958,32.0408743924,31.838239008808,3,2,452,461,sp|Q14764|MVP_HUMAN Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4,Unmodified
QVLSYGQN(N-Glycosylation)LSFSFR{Fuc:1; Hex:5; HexNAc:7; Neu5Ac:2},4604.881393971979,2.8400052057514517e-06,9.96055464683,19.2557907087,0.00751879699248,177144872.5,86.8635151452,87.451181311,87.102208843454,3;4,2,568,582,sp|P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3,Unmodified
QVLSYGQN(N-Glycosylation)LSFSFR{Fuc:2; Hex:7; HexNAc:4},3883.65696508,-7.18090098085e-06,0,10.7386141396,0.0416666666667,0,,,,3,1,568,582,sp|P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3,
GSTRFN(N-Glycosylation)K{Hex:7; HexNAc:2},2348.929845425187,7.583969375556811e-06,14.4328805651,79.6459270927,0,450686852.0,28.8484454261,29.3333037442,29.043265508238,2,1,2939,2946,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
FN(N-Glycosylation)KTKTFR{Hex:9; HexNAc:5; Neu5Ac:1},3805.5515311737827,-1.8728859575032274e-06,8.393985936,41.6625900683,0,34810830.0,71.9730878618,72.205795243,72.143190994485,3,1,2943,2951,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
LLEN(N-Glycosylation)MTEVVR{Fuc:2; Hex:8; HexNAc:5},3806.55485785,3.49874893623e-06,0,27.7893012727,0,0,,,,3,1,604,614,sp|Q6P996|PDXD1_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PDXDC1 PE=1 SV=2,
LLEN(N-Glycosylation)M(Oxidation)TEVVR{Fuc:2; Hex:8; HexNAc:5},3822.57027526,-1.87942397997e-06,0,18.4484365279,0.00751879699248,0,,,,3,1,604,614,sp|Q6P996|PDXD1_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PDXDC1 PE=1 SV=2,
SLLIKN(N-Glycosylation)NSLPR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:2},3970.71042835,-0.000252426682292,0,22.8647562376,0,0,,,,3,1,893,904,sp|Q68E01|INT3_HUMAN Integrator complex subunit 3 OS=Homo sapiens OX=9606 GN=INTS3 PE=1 SV=1,
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4498.024848223732,-5.4765044400953785e-06,7.31447078267,18.0693301586,0.00751879699248,66228427.0,68.377718495,68.5628151761,68.532572375361,3;4,1,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,Unmodified
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Fuc:2; Hex:5; HexNAc:4},4061.89038373,-5.68532728831e-06,0,16.2790438602,0.00751879699248,0,,,,4,1,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},4352.95905321,8.39394578352e-07,0,12.8141743432,0.0320512820513,0,,,,4,1,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,
IGGAQN(N-Glycosylation)RSYSK{Fuc:3; Hex:5; HexNAc:5},3443.42938168,1.44002342451e-06,0,106.539930274,0,0,,,,3,1,67,78,sp|P14174|MIF_HUMAN Macrophage migration inhibitory factor OS=Homo sapiens OX=9606 GN=MIF PE=1 SV=4,
LEIC(Carbamidomethyl)N(N-Glycosylation)LTPDALKSR{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3526.567290293037,-8.390528080407496e-06,14.5761369213,18.1532548679,0.00751879699248,128715522.25,43.3253014948,43.5653060105,43.446175744756,3,1,347,361,sp|P07384|CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN1 PE=1 SV=1,Unmodified
DFFLAN(N-Glycosylation)ASR{Fuc:2; Hex:6; HexNAc:4},3116.26687666,-2.54616309016e-06,0,17.1662972789,0,0,,,,3,1,462,471,sp|P07384|CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN1 PE=1 SV=1,
LEIC(Carbamidomethyl)N(N-Glycosylation)LTPDALK{Hex:5; HexNAc:2},2602.187358898524,-1.615745346709851e-05,-5.11256777628,17.0584619572,0.00751879699248,17878629.25,61.3272020922,61.5407871113,61.464302558327,3,2,347,359,sp|P07384|CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN1 PE=1 SV=1,Unmodified
YPSLANRN(N-Glycosylation)GTKYLAR{Hex:5; HexNAc:4},3345.5143035497954,-4.825781548215023e-06,10.1396630994,20.1472593995,0,13648122.75,80.1392728434,80.2651585247,80.201996642971,3,2,272,287,sp|O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens OX=9606 GN=DNM1L PE=1 SV=2,Unmodified
ATAIN(N-Glycosylation)ASRALKSLIPLYQNFYEER{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},5119.33051697,-2.74517581234e-06,0,21.593764635,0,0,,,,4,1,1973,1997,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,
LQVELDN(N-Glycosylation)VTGLLSQSDSK{Fuc:1; Hex:8; HexNAc:8},5012.081575230462,6.843762090298743e-06,2.52308288458,16.6469045518,0.00751879699248,49794621.5,66.1766486591,66.2693631437,66.269363143667,4;5,1,1277,1295,sp|P35579|MYH9_HUMAN Myosin-9 OS=Homo sapiens OX=9606 GN=MYH9 PE=1 SV=4,Unmodified
LLGN(N-Glycosylation)SSPR{Hex:8; HexNAc:5},3154.2585053256253,6.962048464834222e-06,11.7398981845,102.000744501,0,171059637.5,45.5279474086,45.7984294282,45.647800726318,2;3,2,646,654,sp|P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1,Unmodified
LLGN(N-Glycosylation)SSPR{Hex:9; HexNAc:5},3316.313440526408,5.985054988810931e-06,11.1891668357,98.7327826731,0,266929661.25,45.1193450596,45.4991649097,45.370803410435,2;3,2,646,654,sp|P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens OX=9606 GN=LMNA PE=1 SV=1,Unmodified
QLPLVKPYLRSVQNHNN(N-Glycosylation)K{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4003.8603158204064,-2.0981112438171527e-06,14.1519222906,19.5616531764,0.00751879699248,133590968.75,65.9762710915,66.2075561271,66.13177391154,3,1,1443,1461,sp|Q00610|CLH1_HUMAN Clathrin heavy chain 1 OS=Homo sapiens OX=9606 GN=CLTC PE=1 SV=5,Unmodified
QLPLVKPYLRSVQNHNN(N-Glycosylation)K{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4206.941779872059,-2.4939913692062878e-06,12.0333956483,17.7308568902,0.00751879699248,89040648.25,65.5732211775,65.7759912278,65.66730962855,3;4,2,1443,1461,sp|Q00610|CLH1_HUMAN Clathrin heavy chain 1 OS=Homo sapiens OX=9606 GN=CLTC PE=1 SV=5,Unmodified
QLPLVKPYLRSVQNHNN(N-Glycosylation)K{Hex:5; HexNAc:4; Neu5Ac:1},4060.8853554822667,-2.9492301774764583e-06,11.8560494051,12.22108342,0.0368098159509,79480204.75,65.7600912438,65.9460568772,65.853887044017,3,1,1443,1461,sp|Q00610|CLH1_HUMAN Clathrin heavy chain 1 OS=Homo sapiens OX=9606 GN=CLTC PE=1 SV=5,Unmodified
VN(N-Glycosylation)RSTALLK{Fuc:1; Hex:7; HexNAc:4; Neu5Ac:2},3675.546688236059,-2.1122652539885914e-06,14.9840464655,69.1533774937,0,704836427.75,31.764345728,32.2724009937,31.997479393705,3;4,2,3471,3480,sp|Q14204|DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens OX=9606 GN=DYNC1H1 PE=1 SV=5,Unmodified
VYKPSAGN(N-Glycosylation)NSLYR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3818.609945872497,-8.529325872269345e-06,12.0186114327,62.3746457677,0,110842233.25,39.7837915447,40.1408747779,40.020258159065,3,1,154,167,sp|P02749|APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens OX=9606 GN=APOH PE=1 SV=3,Unmodified
SSFLQVFN(N-Glycosylation)NSPDESSYYR{Fuc:3; Hex:5; HexNAc:4},4199.75021593,-9.61235840108e-06,0,12.7992482709,0.0320512820513,0,,,,3,1,586,604,sp|Q15436|SC23A_HUMAN Protein transport protein Sec23A OS=Homo sapiens OX=9606 GN=SEC23A PE=1 SV=2,
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9080424607887,-3.520301855020913e-06,18.7922581744,89.1650202092,0,1343794054.75,28.7627499765,29.0844119257,28.876711359247,2;3,1,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8019128343635,-3.887415466099939e-06,14.9545207719,88.9108488866,0,133934769.5,29.3333037442,29.5153515603,29.390136991564,2,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
NIPLLFLQN(N-Glycosylation)ITGFM(Oxidation)VGR{Fuc:1; Hex:8; HexNAc:3},4000.82104315,-0.000260444054386,0,10.3388617815,0.046511627907,0,,,,3,1,394,411,"sp|Q9HCC0|MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Homo sapiens OX=9606 GN=MCCC2 PE=1 SV=1",
VKAEGPGLN(N-Glycosylation)R{Hex:8; HexNAc:4},3148.314484440607,9.640716255976553e-07,13.6175544925,21.541638163,0,228510295.5,42.1516857094,42.5513842609,42.344469792271,3,2,869,879,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,Unmodified
VKAEGPGLN(N-Glycosylation)R{Hex:6; HexNAc:4},2824.208698493209,1.1239647631099308e-06,13.3219122734,16.4439338721,0.00751879699248,331728531.5,42.7759246932,43.1896992431,42.968012442811,3,1,869,879,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,Unmodified
LKWLN(N-Glycosylation)R{Fuc:1; Hex:7; HexNAc:7; Neu5Ac:1},3821.557856210911,4.67027526490494e-06,10.3739216368,94.9339355719,0,284872703.25,56.8674921936,57.4476054416,57.201322776699,3;4,2,2135,2141,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,Unmodified
IIQRN(N-Glycosylation)R{Fuc:3; Hex:6; HexNAc:6},3427.45258888,-9.53251181819e-07,0,93.8513045365,0,0,,,,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",
IGLFN(N-Glycosylation)SSADRVK{Hex:6; HexNAc:4; Neu5Ac:2},3672.5510688354234,-5.91032029410338e-06,15.2778222883,21.0607596508,0,390430145.0,39.7388381944,40.2587938772,39.945229993884,3,2,462,474,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
EHEN(N-Glycosylation)NTDVLGK{Hex:12; HexNAc:2},3605.378677535668,-5.568783551546111e-07,12.2562900613,27.0348592345,0,234971036.25,59.4551067617,59.9310523774,59.668489061419,3,2,1429,1440,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,Unmodified
IM(Oxidation)KLSNEIETATRSITNN(N-Glycosylation)VSQIK{Fuc:1; Hex:6; HexNAc:4; Neu5Ac:2},5118.29402233,-7.09886488011e-06,0,21.854568926,0,0,,,,4,1,960,983,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,
GIDN(N-Glycosylation)RTQK{Fuc:4; Hex:6; HexNAc:5},3502.4340804207854,-9.971888341421276e-08,13.9092037462,13.2544977362,0.0238095238095,404208463.0,41.7378953284,42.3742197778,42.093805192534,3,2,52,60,sp|Q9Y6E0|STK24_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens OX=9606 GN=STK24 PE=1 SV=1,Unmodified
KN(N-Glycosylation)LSYAPGYR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},3024.2599107803053,-2.2943160170708947e-07,4.51444829559,15.8586883338,0.00751879699248,37867462.5,57.7665873434,58.2825903283,57.842566560332,3,1,487,497,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,Unmodified
VTFGLNRN(N-Glycosylation)MTAEFKK{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3652.62647128,-8.37409621277e-06,0,18.4744219843,0.00751879699248,0,,,,3,1,683,698,sp|Q14684|RRP1B_HUMAN Ribosomal RNA processing protein 1 homolog B OS=Homo sapiens OX=9606 GN=RRP1B PE=1 SV=3,
LEREERN(N-Glycosylation)QTQVLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3729.646686573954,-6.910652509472611e-06,12.5591755879,50.3706941806,0,228619055.25,43.3103811091,43.5965079254,43.400735877577,3;4,2,277,290,sp|Q96CS3|FAF2_HUMAN FAS-associated factor 2 OS=Homo sapiens OX=9606 GN=FAF2 PE=1 SV=2,Unmodified
LEREERN(N-Glycosylation)QTQVLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4020.7291717364915,-3.1941838789594554e-06,16.2879609723,43.7646343988,0,1327098372.0,45.9031794773,46.411187711,46.126171241824,3;4,4,277,290,sp|Q96CS3|FAF2_HUMAN FAS-associated factor 2 OS=Homo sapiens OX=9606 GN=FAF2 PE=1 SV=2,Unmodified
LEREERN(N-Glycosylation)QTQVLR{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3567.5830894778364,-4.204699439539482e-06,12.2032364075,20.3990912784,0,101405705.5,43.6993269946,43.8490256614,43.774791608874,3,2,277,290,sp|Q96CS3|FAF2_HUMAN FAS-associated factor 2 OS=Homo sapiens OX=9606 GN=FAF2 PE=1 SV=2,Unmodified
LERN(N-Glycosylation)FTVSAVIFK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3873.6969488198574,-4.088167873467883e-06,13.2639262517,55.7590577971,0,462660572.0,48.7956517087,49.1406212952,48.975914727275,3;4,4,151,164,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
N(N-Glycosylation)FTVSAVIFKK{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:2},3968.6977066516465,-4.334744837698501e-06,9.11242248797,52.0751276476,0,158239305.0,89.1710176256,89.5959211614,89.249114710712,3,1,154,165,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
LERN(N-Glycosylation)FTVSAVIFK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3582.603601123528,-4.997799240758332e-06,11.5516354872,50.0043697871,0,98147293.5,46.0074840095,46.1559844282,46.082694493357,3,2,151,164,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
N(N-Glycosylation)FTVSAVIFKK{Fuc:3; Hex:6; HexNAc:5; Neu5Ac:1},3969.7064950677573,-1.4083198857515937e-06,-21.5566976868,48.5295310398,0,13293074.5,89.4546119597,89.6917494085,89.45461195968,3,3,154,165,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
N(N-Glycosylation)FTVSAVIFKK{Fuc:3; Hex:6; HexNAc:5},3678.616236314715,-2.921851406727001e-06,-21.6281251681,47.330853332,0,4940449,83.617049494,83.617049494,83.617049494012,3,2,154,165,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
LERN(N-Glycosylation)FTVSAVIFK{Fuc:1; Hex:4; HexNAc:4},3129.4503610553193,-4.123724242290883e-06,12.8130995809,14.1006945181,0.0204081632653,42991804.5,43.6549651927,43.7295090105,43.684610794608,3,1,151,164,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
HARWFEEN(N-Glycosylation)ASQSTVK{Fuc:1; Hex:8; HexNAc:8},4855.94377145,5.36459556488e-06,0,16.0304102054,0.00751879699248,0,,,,4,1,206,221,sp|Q12905|ILF2_HUMAN Interleukin enhancer-binding factor 2 OS=Homo sapiens OX=9606 GN=ILF2 PE=1 SV=2,
RDNPKPN(N-Glycosylation)VSEALR{Hex:3; HexNAc:2},2387.1359516642356,-1.191714862984594e-05,10.5470872041,16.2093454165,0.00751879699248,153743771.25,39.3680916256,39.7100395427,39.516572394594,4,1,28,41,sp|P82909|KGD4_HUMAN Alpha-ketoglutarate dehydrogenase component 4 OS=Homo sapiens OX=9606 GN=MRPS36 PE=1 SV=2,Unmodified
VREIRYQGGN(N-Glycosylation)R{Fuc:1; Hex:6; HexNAc:4},3277.400951901676,2.4767000203586147e-06,15.0480809067,59.2633965392,0,292447894.25,25.7367127445,25.8956884609,25.79506154321,3;4,2,1564,1575,sp|P04275|VWF_HUMAN von Willebrand factor OS=Homo sapiens OX=9606 GN=VWF PE=1 SV=4,Unmodified
LIDNN(N-Glycosylation)K{Hex:4; HexNAc:3},1972.8426048491406,-3.4164198016774423e-06,14.8334086584,11.1670153861,0.0352941176471,170445954.5,26.5650405433,26.732840942,26.633272245153,2,2,327,333,sp|P07602|SAP_HUMAN Prosaposin OS=Homo sapiens OX=9606 GN=PSAP PE=1 SV=2,Unmodified
ERGRN(N-Glycosylation)WSR{Hex:5; HexNAc:2},2275.950374455572,2.069919586496626e-06,16.7965371737,97.4357570738,0,735674752.75,62.1712489591,62.7368543611,62.44907489481,2,2,2117,2125,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
ERGRN(N-Glycosylation)WSR{Hex:6; HexNAc:2},2438.0030050220817,2.0114356866596676e-06,14.012060852,80.8422282713,0,234468754.0,61.8618393447,62.294758243,61.985494711622,2,2,2117,2125,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
ERGRN(N-Glycosylation)WSR{Hex:7; HexNAc:2},2600.0628754110207,-8.242432175517574e-07,11.2766181537,66.289326779,0,12957063.625,61.6623832093,61.7998353428,61.739064545059,2,2,2117,2125,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
N(N-Glycosylation)VSSSKGSPAPLGVRSK{Fuc:1; Hex:4; HexNAc:4},3276.486340107961,3.5050863263440854e-06,11.1342810931,18.8087296011,0.00751879699248,104727195.5,41.2623932268,41.4404969599,41.382497074827,3,2,217,234,sp|O15117|FYB1_HUMAN FYN-binding protein 1 OS=Homo sapiens OX=9606 GN=FYB1 PE=1 SV=2,Unmodified
ELSLVNKN(N-Glycosylation)K{Fuc:1; Hex:8; HexNAc:7},3907.6206122620424,3.326954233172798e-06,11.1815537272,36.4386459027,0,58243388.5,71.1528228428,71.3236063944,71.246449608231,3,1,21,30,sp|Q9UHB6|LIMA1_HUMAN LIM domain and actin-binding protein 1 OS=Homo sapiens OX=9606 GN=LIMA1 PE=1 SV=1,Unmodified
LQMWVDLFPKALGRPGPPFN(N-Glycosylation)ITPRR{Fuc:2; Hex:4; HexNAc:5},4861.32209461357,-1.641026121222377e-06,-21.7423485955,22.4192060431,0,18399414,96.2482314931,96.2482314931,96.24823149306,4,1,1782,1807,sp|O75923|DYSF_HUMAN Dysferlin OS=Homo sapiens OX=9606 GN=DYSF PE=1 SV=1,Unmodified
KQNN(N-Glycosylation)FSLAMK{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3442.44163756,-5.89827657759e-06,0,79.1404821407,0,0,,,,3,1,3247,3257,sp|P78527|PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens OX=9606 GN=PRKDC PE=1 SV=3,
AN(N-Glycosylation)KTITSLNLDSNHITGKGILAIFR{Fuc:5; Hex:7; HexNAc:8},6185.80012195732,-1.371844974345853e-06,-20.1805903197,15.6291126886,0.00751879699248,18918736,91.9327344444,91.9327344444,91.932734444364,4,1,384,409,sp|P29536|LMOD1_HUMAN Leiomodin-1 OS=Homo sapiens OX=9606 GN=LMOD1 PE=1 SV=3,Unmodified
N(N-Glycosylation)LTFNITKTIR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3670.6118688726474,-6.915750818818854e-06,13.2457660597,55.7411382489,0,204462563.5,48.825952159,49.0951608922,48.872038478279,3,2,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
NLTFN(N-Glycosylation)ITKTIR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3670.6118688726474,-6.915750818818854e-06,13.2457660597,55.7411382489,0,204462563.5,48.825952159,49.0951608922,48.872038478279,3,2,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
VQPRVN(N-Glycosylation)VSPSK{Fuc:2; Hex:5; HexNAc:4},3124.38671674,-2.0234557735e-06,0,21.8457267399,0,0,,,,3,1,121,132,"sp|P04440|DPB1_HUMAN HLA class II histocompatibility antigen, DP beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",
EHPAARQIELDLN(N-Glycosylation)R{Hex:6; HexNAc:5; Neu5Ac:1},3939.69066838,-4.29797181951e-06,0,11.0479012068,0.0416666666667,0,,,,3,1,662,676,sp|Q9BYX2|TBD2A_HUMAN TBC1 domain family member 2A OS=Homo sapiens OX=9606 GN=TBC1D2 PE=1 SV=3,
N(N-Glycosylation)C(Carbamidomethyl)TSFRAR{Hex:6; HexNAc:4},2795.1032238715907,1.0032704892018272e-06,16.3434032295,76.6651125742,0,998959993.25,27.0871687081,27.5168295767,27.239551892503,2;3,4,633,641,sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2,Unmodified
N(N-Glycosylation)NSWVK{Fuc:5; Hex:7; HexNAc:6},3829.5127189,-1.57670524514e-06,0,33.4136973099,0,0,,,,5,1,524,530,sp|Q9P2B2|FPRP_HUMAN Prostaglandin F2 receptor negative regulator OS=Homo sapiens OX=9606 GN=PTGFRN PE=1 SV=2,
AVDHATN(N-Glycosylation)R{Fuc:2; Hex:6; HexNAc:6},3365.34108139,-3.89316321408e-07,0,14.0990420703,0.0120481927711,0,,,,3,1,358,366,"sp|P49748|ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",
N(N-Glycosylation)DSLRK{Fuc:1; Hex:4; HexNAc:3},2134.892408010954,3.5194224109413267e-06,17.6433031983,39.0201600591,0,1070928117.0,26.372268127,26.6059542444,26.48212137483,2;3,2,187,193,sp|Q15631|TSN_HUMAN Translin OS=Homo sapiens OX=9606 GN=TSN PE=1 SV=1,Unmodified
RGFFNLN(N-Glycosylation)R{Fuc:2; Hex:7; HexNAc:4; Neu5Ac:1},3552.4455188868897,-1.6984463541295805e-06,-21.2516287351,87.3824265506,0,4556281,67.4552904433,67.4552904433,67.455290443325,3,3,42,50,sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,Unmodified
RGFFNLN(N-Glycosylation)R{Hex:7; HexNAc:4; Neu5Ac:2},3551.4342688780066,-4.2756586542248345e-06,12.1283105683,72.8934973205,0,270159184.75,67.4703716781,68.2699694262,67.944131094837,3,3,42,50,sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,Unmodified
GFFNLN(N-Glycosylation)RSSKR{Fuc:1; Hex:4; HexNAc:4},2931.2978440737006,-3.7985097089066084e-06,13.1867354176,60.9195005487,0,117052440.0,28.7627499765,28.9053416914,28.806015092754,3,2,43,54,sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,Unmodified
QLALLLWKN(N-Glycosylation)YTLQK{Hex:5; HexNAc:2},2947.4191770639527,4.075379654410238e-06,14.6933001888,12.040193986,0.0368098159509,340377124.75,82.3702676918,82.7811792757,82.55952809515,2;3,1,5,19,sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2,Unmodified
QLALLLWKN(N-Glycosylation)YTLQK{Hex:6; HexNAc:2},3109.458508767076,8.2019320895186e-06,15.5128580215,11.9123891067,0.0368098159509,329725860.0,82.0717942582,82.4331528253,82.229801041508,2;3,1,5,19,sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2,Unmodified
LARN(N-Glycosylation)ESR{Fuc:1; Hex:7; HexNAc:7; Neu5Ac:1},3837.557055368155,-6.995354119172091e-06,9.14497087696,22.1160582909,0,71056052.5,48.0550601747,48.4326375749,48.327512143675,3;4,1,478,485,sp|O43516|WIPF1_HUMAN WAS/WASL-interacting protein family member 1 OS=Homo sapiens OX=9606 GN=WIPF1 PE=1 SV=3,Unmodified
FEVFKN(N-Glycosylation)GTLR{Hex:5; HexNAc:4; Neu5Ac:1},3123.351928620361,-7.779394834900987e-06,12.5957722877,70.9559495171,0,464436653.0,69.8834232754,70.4533546434,70.069078559303,2;3,4,457,467,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,Unmodified
N(N-Glycosylation)ITLDDASAPRLM(Oxidation)VLR{Hex:5; HexNAc:4; Neu5Ac:2},4004.7341909378983,-1.3440365857080785e-06,9.85069009478,18.715930108,0,108006308.0,57.1557868427,57.3709387925,57.232037475332,3;4,3,758,774,sp|O75534|CSDE1_HUMAN Cold shock domain-containing protein E1 OS=Homo sapiens OX=9606 GN=CSDE1 PE=1 SV=2,Unmodified
KMWKSPN(N-Glycosylation)GTIR{Hex:6; HexNAc:3},2898.2848628155157,-9.481223815581855e-06,14.6481683907,13.6156265921,0.0204081632653,6274454398.5,45.5279474086,46.7397430088,46.320476061726,3;4;5;6,1,129,140,"sp|P48735|IDHP_HUMAN Isocitrate dehydrogenase [NADP], mitochondrial OS=Homo sapiens OX=9606 GN=IDH2 PE=1 SV=2",Unmodified
SWPSPKN(N-Glycosylation)R{Hex:9; HexNAc:5},3444.38732509,-4.8159819251e-06,0,83.9472046113,0,0,,,,3,1,1431,1439,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3677.6217077112497,-7.633413320108356e-06,13.4888795112,28.2522575476,0,325392424.25,82.9220972763,83.6949875262,83.347690410042,3,4,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
TVN(N-Glycosylation)VSVPKKTR{Fuc:1; Hex:6; HexNAc:5},3361.500592680696,3.091869583049733e-07,8.27387958056,61.1942147213,0,24507681.0,76.5572835591,76.6829751081,76.557283559068,3,2,88,99,sp|Q96KA5|CLP1L_HUMAN Lipid scramblase CLPTM1L OS=Homo sapiens OX=9606 GN=CLPTM1L PE=1 SV=1,Unmodified
RKPN(N-Glycosylation)YSSVDLSEVEWEDR{Hex:8; HexNAc:2},3910.6443952,-4.68924454076e-06,0,13.3667670748,0.0204081632653,0,,,,3,1,549,567,sp|Q8IZS8|CA2D3_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Homo sapiens OX=9606 GN=CACNA2D3 PE=1 SV=1,
N(N-Glycosylation)ATQRM(Oxidation)FEIDYSRDSFLK{Fuc:1; Hex:9; HexNAc:5},4855.97004701,3.78961655069e-06,0,19.2444905404,0.00751879699248,0,,,,4,1,25,43,sp|P16278|BGAL_HUMAN Beta-galactosidase OS=Homo sapiens OX=9606 GN=GLB1 PE=1 SV=2,
VSN(N-Glycosylation)YSR{Hex:6; HexNAc:4; Neu5Ac:2},3091.1935104015283,-5.7726560852522325e-06,14.3006289342,67.4360745447,0,414850463.0,25.8238969273,26.2482710427,25.966422826672,3,2,198,204,sp|P15328|FOLR1_HUMAN Folate receptor alpha OS=Homo sapiens OX=9606 GN=FOLR1 PE=1 SV=3,Unmodified
ADLVN(N-Glycosylation)R{Hex:9; HexNAc:4},2957.159524481404,1.526535920175963e-06,11.9223397119,70.2978673942,0,178266476.5,27.1006013102,27.3645237273,27.169966509565,3,2,374,380,sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,Unmodified
KPN(N-Glycosylation)VSPEK{Fuc:1; Hex:7; HexNAc:6; Neu5Ac:1},3687.5023744955497,-3.001730354391812e-06,8.84708549887,74.2118113305,0,78913479.0,62.8116169081,63.1501595285,62.873863826815,3,2,149,157,sp|Q9HCH5|SYTL2_HUMAN Synaptotagmin-like protein 2 OS=Homo sapiens OX=9606 GN=SYTL2 PE=1 SV=3,Unmodified
LN(N-Glycosylation)LSIWHRDTFKR{Fuc:2; Hex:5; HexNAc:6},4005.7361719619303,9.025951584756675e-06,9.95716600023,13.0848251345,0.0263157894737,23871523.0,57.1256416426,57.4316686934,57.170721342786,3,1,713,726,sp|Q9HCH5|SYTL2_HUMAN Synaptotagmin-like protein 2 OS=Homo sapiens OX=9606 GN=SYTL2 PE=1 SV=3,Unmodified
ALKN(N-Glycosylation)YTK{Hex:7; HexNAc:5},2986.262379504405,-6.747585829448038e-06,15.5794328414,54.4353122533,0,825150455.0,42.3595364597,43.0128908779,42.581947559738,2;3,2,245,252,sp|Q96MW7|TIGD1_HUMAN Tigger transposable element-derived protein 1 OS=Homo sapiens OX=9606 GN=TIGD1 PE=1 SV=1,Unmodified
QN(N-Glycosylation)KSPDTEK{Hex:6; HexNAc:4},2830.1527137621983,-5.045904992687936e-06,10.0713296916,19.4016541112,0,153255833.5,46.0531657603,46.411187711,46.216175443554,2;3,1,578,587,sp|Q8NDH2|CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=3,Unmodified
GLPSIN(N-Glycosylation)TSLLTPPYLKFDTTEGQENVIR{Fuc:1; Hex:8; HexNAc:8},6169.772292074932,-5.36252725967008e-06,-5.82713831179,12.7942565016,0.0320512820513,34974361,91.901784359,91.9964636272,91.901784359042,4,2,5068,5096,sp|Q8NDH2|CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=3,Unmodified
SLPGN(N-Glycosylation)RSVVRLAVTILDIGPGTLFK{Hex:7; HexNAc:4; Neu5Ac:1},4860.322101063851,-3.5644624761216117e-06,12.0852424528,22.8423401482,0,164343837.0,86.0396287785,86.2941443271,86.150799511496,4;5,1,139,164,sp|Q86Y34|AGRG3_HUMAN Adhesion G protein-coupled receptor G3 OS=Homo sapiens OX=9606 GN=ADGRG3 PE=1 SV=1,Unmodified
M(Oxidation)AVRLAGGLQKM(Oxidation)VALLN(N-Glycosylation)K{Fuc:3; Hex:5; HexNAc:4},4004.862959129145,-1.5896984190580013e-06,-5.24123500694,10.6748543825,0.046511627907,11154714.75,66.0846500939,66.2229215608,66.100274509811,3;4,1,270,288,sp|P35222|CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens OX=9606 GN=CTNNB1 PE=1 SV=1,Unmodified
AN(N-Glycosylation)KTPIRM(Oxidation)R{Fuc:4; Hex:8; HexNAc:8},4606.87775836,4.15498723495e-06,0,16.6108474198,0,0,,,,3,2,21151,21160,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
VDM(Oxidation)NDAGN(N-Glycosylation)FTC(Carbamidomethyl)R{Hex:7; HexNAc:6},3767.42714947,-5.46826460172e-06,0,15.5241612018,0.00751879699248,0,,,,3,1,5101,5113,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
LRAELDEVN(N-Glycosylation)KSAK{Fuc:1; Hex:7; HexNAc:6},3970.6863439,4.28645364687e-06,0,11.6604849741,0.0416666666667,0,,,,3,1,123,136,sp|Q03252|LMNB2_HUMAN Lamin-B2 OS=Homo sapiens OX=9606 GN=LMNB2 PE=1 SV=4,
NVLLN(N-Glycosylation)NSEKMK{Fuc:1; Hex:6; HexNAc:3},3016.2731588403026,6.872499497202479e-06,11.86554373,17.8961523632,0.00751879699248,183511663.75,42.566564344,43.0422721094,42.938480042044,3,2,568,579,sp|Q08J23|NSUN2_HUMAN RNA cytosine C(5)-methyltransferase NSUN2 OS=Homo sapiens OX=9606 GN=NSUN2 PE=1 SV=2,Unmodified
AQRFGLN(N-Glycosylation)VSSISR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:3},4441.83261199,-0.000225298986828,0,17.3523387084,0.00751879699248,0,,,,3,1,153,166,sp|P82979|SARNP_HUMAN SAP domain-containing ribonucleoprotein OS=Homo sapiens OX=9606 GN=SARNP PE=1 SV=3,
IRN(N-Glycosylation)RSYIDR{Hex:5; HexNAc:2},2408.048361662759,9.033697020854093e-06,-21.1242803573,10.4633872522,0.0449438202247,683277.0625,99.9732014285,99.9890737083,99.973201428477,3,1,156,165,sp|Q9H2U1|DHX36_HUMAN ATP-dependent DNA/RNA helicase DHX36 OS=Homo sapiens OX=9606 GN=DHX36 PE=1 SV=2,Unmodified
